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Background: Spirometric parameters are the mainstay for diagnosis of COPD, but cannot distinguish airway
obstruction from emphysema. We aimed to develop a computer model that quantifies airway collapse on forced
expiratory flow–volume loops. We then explored and validated the relationship of airway collapse with computed
tomography (CT) diagnosed emphysema in two large independent cohorts.
Methods: A computer model was developed in 513 Caucasian individuals with ≥15 pack-years who performed
spirometry, diffusion capacity and CT scans to quantify emphysema presence. The model computed the two best
fitting regression lines on the expiratory phase of the flow-volume loop and calculated the angle between them.
The collapse was expressed as an Angle of collapse (AC) which was then correlated with the presence of emphysema.
Findings were validated in an independent group of 340 individuals.
Results: AC in emphysema subjects (N = 251) was significantly lower (131° ± 14°) compared to AC in subjects without
emphysema (N = 223), (152° ± 10°) (p < 0.0001). Multivariate regression analysis revealed AC as best indicator of visually
scored emphysema (R2 = 0.505, p < 0.0001) with little significant contribution of KCO, %predicted and FEV1, %predicted
to the total model (total R2 = 0.626, p < 0.0001). Similar associations were obtained when using CT-automated density
scores for emphysema assessment. Receiver operating characteristic (ROC) curves pointed to 131° as the best cut-off
for emphysema (95.5% positive predictive value, 97% specificity and 51% sensitivity). Validation in a second group
confirmed the significant difference in mean AC between emphysema and non-emphysema subjects. When applying
the 131° cut-off, a positive predictive value of 95.6%, a specificity of 96% and a sensitivity of 59% were demonstrated.
Conclusions: Airway collapse on forced expiration quantified by a computer model correlates with emphysema. An
AC below 131° can be considered as a specific cut-off for predicting the presence of emphysema in heavy smokers.
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Lung collapseBackground
Chronic Obstructive Pulmonary Disease (COPD) is char-
acterized by airflow limitation that is not fully reversible,
usually progressive and associated with an abnormal
inflammatory response of the lung to noxious particles
or gases, most often from cigarette smoke [1]. Being
4th leading cause of death, COPD is one of the major* Correspondence: Wim.Janssens@uzleuven.be
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reproduction in any medium, provided the orhealth challenges of the next decades, while the World
Health Organization predicts that it will become the
3rd leading cause of death by 2030 [2-4]. Prevalence
surveys indicate that up to almost one quarter of the
adults aged 40 years and older may have mild airflow
obstruction [5]. One of the challenges in such pandemic is
to identify patients at risk for rapid deterioration and to
develop diagnostic tools and specific treatment strategies
which are directed to clinically important subgroups or
particular phenotypes with poor outcome [6,7].ral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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phenotypes in COPD. It is characterized by the loss of
lung tissue leading to breakdown of alveolar walls and
subsequent airway collapse during forced expiration. It
has been demonstrated that emphysema is associated
with lower body mass index and bone mineral density,
reduced exercise capacity, impaired quality of life and
higher BODE index compared to COPD patients with
similar airflow obstruction without emphysema [8-12].
Emphysema is, independently of COPD, a strong risk
factor for lung cancer [13,14] and CT screening may be
most beneficial for this particular subgroup [13,15].
Additionally, subtypes of emphysema patients may be
referred for endoscopic valve placement, bullectomy or
even lung volume reduction surgery. As most common
variables obtained by spirometry do not accurately
reflect emphysema presence, the diagnosis is currently
based on CT scan of the chest, which is expensive, not
routinely available and therefore not imposed every time a
new diagnosis of COPD is made. Decreased variables of
diffusing capacity such as DL,CO and KCO are often used
as a surrogate marker of emphysema, for instance in the
differential diagnosis with asthma, because they basically
reflect impaired oxygen uptake by the loss of alveoli
typically observed when the parenchyma is destroyed
[16,17]. Again, these measures need more advanced
equipment restricting the analysis to respiratory physicians
in secondary care. An alternative approach, however,
may be found in the correct quantification of collapse
during the forced expiratory phase of a flow-volume
loop, the so-called ‘spirographic kink’. This kink, suddenly
diminished expiratory flow, has been linked to emphysema
in the past but the association has only been based on
visual assessments in limited patient samples [18-20]. We
therefore hypothesized that a standardized quantification
of collapse may offer a more precise indication of
emphysema presence, which would be of particular
interest in primary care.
In the present study our objective was first to develop a
mathematical model for precise computerized quantifica-
tion of airway collapse on forced expiratory flow-volume
loops. Secondly, we related these measures of airway
collapse to CT-diagnosed emphysema in two large
independent cohorts of smoking individuals.
Methods
Study subjects
To develop the computer model we included data of 513
individuals of the LEUVEN COPD cohort who performed
complete pulmonary function testing at cohort entry
(including post-bronchodilator spirometry and diffusing
capacity) and of whom a computed tomography (CT) scan
was available within 1 year of enrolment. All subjects
were included between October 2007 and January 2009at the University Hospital of Leuven (Belgium), as earlier
described [21,22]. Briefly, participants were all current
or former heavy smokers with at least 15 pack-years and
with minimal age of 50 years. Individuals with suspicion
or diagnosis of asthma were excluded, as well as patients
with exacerbations due to COPD within last 6 weeks
and patients with other respiratory diseases. To validate
findings, a separate cohort of 340 individuals was recruited
between January 2009 and November 2010 at the Univer-
sity Hospital of Leuven. Similar measurements, inclusion
and exclusion criteria were applied. Study was approved
by the local ethical committee of the University Hospital
Leuven, (KU Leuven, Belgium). All patients included in
the study provided informed consent. Study design of
the LEUVEN COPD cohort can be found on www.
clinicaltrials.gov (NCT00858520).Pulmonary function tests
All pulmonary function tests were performed with stan-
dardized equipment (Masterlab, Erich Jeager, Würzburg,
Germany) by respiratory technicians, according to the
ATS/ERS criteria [23]. Spirometry data are post-broncho-
dilator measures and expressed as percent predicted of
normal reference values [24]. Diffusing capacity (DL,CO)
was measured by the single-breath carbon monoxide gas
transfer method and corrected for alveolar ventilation but
not hemoglobin concentration [25]. Patients with COPD
were identified when post-bronchodilator FEV1/FVC ratio
was <0.7, based on international COPD guidelines [26].Emphysema scores
All CT scans were examined by two independent radi-
ologists and visually scored for the presence and extent of
emphysema at 3 predefined levels [21]. The presence of
emphysema, which was defined as an area of hypovascular
low attenuation, was graded at each level with increments
of 5% and averaged as a percentage of total lung tissue
over both lungs. The final scores were the mean percent-
ages taken from scores of both radiologists, resulting in
a linear variable ranging from 0 to 93.3%. Inter-observer
variability determined with intraclass correlation coeffi-
cient (ICC) for the mean scores of the individual radiol-
ogists demonstrated strong agreement and consistency
(ICC = 0.84, p < 0.0001). If emphysema was visually scored
on any of the predefined fields, the patient was categorized
as having emphysema. Additionally, quantification with
CT lung densitometry was performed. The extent of
emphysema was estimated using the percent of voxels
with an X-ray attenuation value below -950 HU. A cut-off
values of ≥1% and ≥10% of total lung volume attenuated
below -950 HU was arbitrarily chosen as being abnormal
and used to identify presence of emphysema [21,27]. A
complete protocol for quantification of emphysema is
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Note S1).
Computer model
To develop a computer model for the calculation of
angle of collapse (AC) we used MATLAB (7.14, The
MathWorks, Natick, Massachusetts). In all individuals
the best expiratory flow-volume curve (highest sum of
FEV1 and FVC) within one spirometry was exported
from the Masterlab system at a sampling rate of 125
Hz. By extracting data points it was possible to recon-
struct the best expiratory manoeuvre in MATLAB and
to develop a unique algorithm for automatic quantifica-
tion of airway collapse (see Results section).
Statistical analysis
Statistical analysis was performed using Statistical Analysis
System (SAS) version 9.3, (SAS Institute, Cary, USA). The
Shapiro-Wilk test was used to control normality of the
datasets, while a T-test was used to evaluate differences in
AC between patients with and without emphysema within
disease severity stages. Linear-regression models were
applied for continuous variables analyses and logistic-
regression models for binary variables. Stepwise selection
was used to identify the subset of variables that had the
strongest relation to emphysema scores, using default
criteria of significance at the 0.15 level to enter or egress
the model. Receiver operating characteristic (ROC) curve
analysis was performed with GraphPad Prism version
5.01, (GraphPad Software, La Jolla, California, USA).
Results
Computer model
The algorithm for quantification of airway collapse
computed the two best fitting regression lines on the
expiratory phase of the flow-volume loop from peak
flow to the end of expiration (Figure 1). The intersection
of both best fitting regression lines determines the angular
point of collapse with the first regression line representing
the best fit of all data points from peak expiratory flow
till collapse and the second line representing the best
fit from collapse till end of FVC. To determine which
couple of regression lines composes the best fit, a can-
didate reference point is created every 10 consecutive
samples starting from peak flow till the end of expiration.
In every step the MSE (mean square error) between the
original data and the fitted lines is calculated with the
lowest MSE designating the most appropriate reference
point. Subsequently, pulmonary function tests with
angles <90° and >180° are rejected, with remaining
measurements ranging from 90° in case of maximal
collapse to 180° when a perfect linear decrease of flow
is present (Figure 2). Only 5.6% (N = 29) of patients
had to be excluded either because AC quantificationfailed or was above the present limit of 180°. The main
reason was a flow volume loop of suboptimal quality.
In 2% (N = 10) of cases emphysema scores were not
obtained from radiologists because of poor CT quality.Baseline characteristics
Baseline characteristics of 474 subjects with good quality
measures of AC and visually assessed emphysema are
presented in Table 1. Emphysema was present in 251
subjects of the total study sample. Mean (±SD) AC in sub-
jects with emphysema was significantly lower 131° (±14°)
compared to 152° (±10°) in subjects without emphysema,
(p < 0.0001). As expected, the prevalence and the extent of
emphysema was much lower in the group of subjects
with normal FEV1/FVC ratio compared to subjects
with a spirometry-based diagnosis of COPD (10% with
median score of 2.1 (0.8-4.8) vs. 71% with a median
score of 35 (8.3-58.5)). In non-COPD subjects AC was not
significantly different between subjects with or without
emphysema (157 ± 5 vs. 156 ± 7, p = 0.73). However, in
COPD patients AC was significantly lower in patients with
emphysema compared to the non-emphysema patients
(130 ± 13 vs. 146 ± 11, p < 0.0001), even when stratifying
according to former GOLD stages of COPD severity
(Table 2). Severity of the disease was staged by FEV1
expressed as percent predicted as stated in former
Global Initiative for Chronic Obstruction Lung Disease
(GOLD) classification [28].Value of AC compared to pulmonary function variables
With univariate linear regression, similar relationships
between emphysema scores and lung function variables
(FEV1/FVC ratio, DL,CO, %predicted) were found as
between emphysema scores and AC. Associations with
FVC, %predicted and FEV1, %predicted were less
pronounced (Table 3). Multivariate linear regression
analysis revealed AC as best indicator of emphysema
extent, not only in stepwise models taking only spirometry
measurements into account (FVC, %predicted, FEV1, %
predicted, FEV1/FVC), but also in models including
both spirometry data and diffusing capacity (KCO, %pre-
dicted, DL,CO, %predicted) (Table 4). Logistic regression
confirmed AC as significant predictor of emphysema
presence whereas in a multivariate model, FEV1/FVC
ratio seemed to be a better determinant (see Additional
file 1: Tables S1 a/ and b/ in the online supplementary
material). When restricting the multivariate logistic
regression to the subgroup of patients with proven
COPD, a significant relationship between emphysema
and AC was confirmed, suggesting that FEV1/FVC
has only superior associations with emphysema in the
population without COPD.
Figure 1 Example of the calculation process with fitting of regression lines to the original data in incremental steps of 10 data points.
Panels A-B show regression lines for a candidate reference point after respectively 10 and 400 data points. Panel C shows all regression lines
together with a highlighted selection of 2 lines in yellow (after 6 steps) having the lowest MSE of all steps, as represented in Panel D.
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We used ROC curve analysis to compute the sensitivity
and specificity of AC for predicting emphysema presence.
An area under the curve of 0.863 (0.830-0.896) was found
to be statistically significant (p < 0.0001). If using maximal
sum of sensitivity and specificity to select best cut-off,
ROC curve pointed to 143°, with specificity of 86% and
sensitivity of 74%. However, if determining the cut-off
based on the clinical need for high specificity and
strong positive predictive value, ROC curve indicated
131° as most appropriate cut-off, with specificity of
97% and sensitivity of 51% (see Figure 3, panel A and
B). An angle ≤131° resulted in a positive predictive
value of 95.5% for the presence of emphysema. From
the 133 subjects categorized as having emphysema
based on the AC, only 6 were misclassified. A similar
approach resulted in a 66% cut-off for KCO, %predicted
and a 0.43 cut-off for the FEV1/FVC ratio with com-
parable results for specificity and sensitivity in predict-
ing the presence of emphysema. When joining both
cut-offs of either 131° for AC or 66%predicted for Kco,
sensitivity rose to 67%, whilst positive predictive value
and specificity remained within the same range (93%
and 95%, respectively).Densitometric quantification of emphysema
Despite the heterogeneous acquisition of CT scans in
our clinical cohort, we also calculated automated density
scores based on Hounsefield Units (HU) to quantify
emphysema. An additional number of 8 patients had to
be excluded due to lack of density scores. When defining
emphysema based on attenuation of at least 1% of the
total lung volume below the -950 HU threshold, 446
(96%) subjects were categorised with emphysema. When
using an arbitrary but more strict approach to define
emphysema (>10% below -950 HU), only 213 patients
were labelled with emphysema, which had also a best
agreement with the obtained visual scores, kappa 0.393
(95%CI: 0.310 -0.476). Subsequent stratification according
to the 10% cut-off demonstrated worse pulmonary
function and significantly lower AC (134° ± 16° ) in the
emphysema group compared to the controls (148° ± 13°)
(p < 0.0001) (online Additional file 1: Table S2). Despite
poor correlations between automated density scores
expressed as proportion of voxels below the -950 HU
threshold and pulmonary function variables (online
Additional file 1: Table S3), multivariate linear regression
still retained AC as best indicator of emphysema (Table 5).
Multivariate logistic regression confirmed AC as significant
Figure 2 Examples of successfully calculated angles of collapse
in different subjects: (A/ AC = 162° B/ AC = 133°C/ AC = 107°).
Table 1 Study population characteristics
No emphysema Emphysema
Patients, n 223 251
COPD, absent/present 124/99 14/237
Sex, M/F 178/45 192/59
Age, years 62 (58 - 67) 65 (59 - 74)
Smoking, pack yr. 40 (30 - 53) 48 (34 - 62)
BMI, kg/m2 27 (±4) 24 (±5)
FEV1, %predicted 91 (±25) 52 (±26)
FVC, %predicted 103 (±20) 88 (±24)
FEV1/FVC 0.68 (±0.11) 0.45 (±0.14)
KCO, %predicted 96 (±17) 69 (±21)
DL,CO, %predicted 82 (±17) 50 (±19)
Emphysema scores, % 0 32 (7 - 57)
Definition of abbreviations: BMI Body mass index, COPD Chronic obstructive
pulmonary disease, DL,CO Carbon monoxide diffusing capacity, F Female, FEV1
Forced expiratory volume in one second, FVC Forced vital capacity, KCO
Carbon monoxide transfer coefficient, M Male, Values are means ± SD;
Emphysema score, age and smoking values are median and IQR.
Table 2 Angle of collapse in different GOLD stages
No Emphysema Emphysema
N AC N AC p value
No COPD 124 156 (±7) 14 157 (±5) 0.7261
GOLD I 48 152 (±6) 29 148 (±5) 0.0056
GOLD II 28 146 (±7) 73 138 (±9) <.0001
GOLD III 16 137 (±6) 81 126 (±9) <.0001
GOLD IV 7 123 (±16) 54 117 (±8) 0.0858
Values are means ± SD.
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Additional file 1: Table S4).
When performing ROC curve analysis, and using high
specificity and strong positive predictive value to select
the best cut-off, ROC curve pointed to 124° but with anexpected lower sensitivity of 67%, specificity of 91% and
positive predictive value of 81% (Online supplement,
Additional file 1: Figure S1).Validation study
Computation of airway collapse was repeated in a similar
independent cohort in which successful quantification
was present in 93.5% (N = 303) of subjects. 6.5% (N = 21)
of subjects were excluded due to exceeded limit of 180° or
failed quantification. Baseline characteristics are described
in Additional file 1: Table S5 (online data supplement).
Of note, emphysema based on visual scores was found
in 182 (60%) of individuals and a significant difference
in mean AC between emphysema and non-emphysema
subjects, 129° ± 16° vs. 151° ± 11° (p < 0.0001), was con-
firmed. Furthermore, when 131°Cut-off for AC was
applied, a specificity of 96% and sensitivity of 59%
were found in the validation set. Positive predictive
value remained very high (95.6%) with only 5 among
113 subjects being misclassified.
Table 3 Relationship between functional variables and
emphysema extent in univariate linear regression model
Variables R2 value p value
FVC, %predicted 0.1427 <.0001
FEV1, %predicted 0.4001 <.0001
FEV1/FVC 0.5030 <.0001
KCO, %predicted 0.4658 <.0001
DL,CO, %predicted 0.5065 <.0001
AC, degrees 0.5033 <.0001
R2 value represents variance explained by the model.
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Our study demonstrates that airway collapse observed at
forced expiration can be automatically quantified by a
computer model as an angle varying from 180° to 90°,
correlating with the presence and severity of emphysema.
Although our method was not sensitive to identify mild
emphysema in the early stages of smoke-induced lung
disease, an angle ≤ 131° proved to be a reliable cut-off
for the positive prediction of emphysema in smoking
individuals.
Emphysema is characterized by the disruption of alveolar
attachments leading to loss of alveolar-airway interdepend-
ence and reduced airway tethering during breathing
[29]. Upon the generation of highly positive intra-thoracic
pressures during forced expiration, airway collapse occurs.
Since many years it is understood that collapse repre-
sented by a spirographic kink in expiratory flow volume
loop is indicative for emphysema [20]. Recent studies
elegantly confirmed reduced airway diameter on CT
scan with the presence of emphysema [30,31]. To the
best of our knowledge, our study is the first to validate
the concept of emphysema-associated airflow collapse
in a larger group of individuals comprising COPD patients
of all severity stages as well as smoking controls. In ourTable 4 Relationship between functional variables and
visual CT-scores of emphysema by multivariate linear
regression model with stepwise selection
Variables Partial R2 value Model R2 value p value
1.
AC, degrees 0.5032 0.5032 <.0001
FEV1/FVC 0.0211 0.5244 <.0001
2.
AC, degrees 0.5056 0.5056 <.0001
KCO, %predicted 0.1137 0.6193 <.0001
FEV1, %predicted 0.0067 0.6260 0.0040
1/ Variables of spirometry (initial model: AC, FVC,%pred, FEV1,%pred, FEV1/
FVC); 2/ Variables of spirometry and diffusion capacity (initial model: AC, FVC,
%pred, FEV1,%pred, FEV1/FVC, DL,CO,%pred, KCO,%pred).population, we found that collapse correlated well with
severity of emphysema and was even better associated
than measures of diffusing capacity in a multivariate
approach, particularly in patients with established diagnosis
of COPD based of FEV1/FVC ratio [32]. Despite the
low sensitivity of our approach, the established cut-off
of 131° yielded a positive predictive value of more than
95%. Revision of all 6 false positive cases revealed that
3 of them had alpha-1-antitrypsin deficiency resulting
in panlobular emphysema. The latter may explain some
misclassification on CT which would indicate an even
higher accuracy [33,34]. Furthermore, when combining
the cut-off of collapse with a potential cut-off of 66%
for Kco, sensitivity improved to 67% for a similar specifi-
city indicating that both measures still provided additional
information for the prediction of emphysema [35].
An important strength of our approach is the use of
a computer model to automatically quantify collapse.
Previous studies have used a beta-angle for quantification
[36]. With the latter method the angular point is fixed
on the flow-volume curve at 50% of FVC, with one leg
through peak flow and the other leg through the X axis
at the end of expiration. A major disadvantage of such
technique is that early collapse after peak flow is often
underestimated whereas airflow limitation at the end of
expiration is overestimated. Our methodology is different
by the fact that our angular point is not obligatory located
on the flow-volume loop but chosen as the intersection
point of best fitting regression lines representative of
the data. Such approach does not only provide a more
exact quantification when collapse is difficult to visualize
or even absent, it also results in a quantification that
closely corresponds to visual estimates when the angle is
obviously present. In this context a visual cut-off of 131° is
clinically useful, especially for primary care physicians
who don’t have standard access to CT scan or diffusing
capacity. Indeed, the identification of emphysema with
spirometry in a subgroup of smoking individuals in
primary care, may envisage early referral for a more
extended testing and, if needed, a more rigorous follow-
up. In the past, other computational methods have
been used to characterise airflow limitations on forced
expiration [37]. One interesting approach, is the assessment
of mean transit time (MTT) as a sensitive indicator of both
large and small airways obstruction [38,39]. It is yet to
be explored whether MTT is also useful in detection of
emphysema at early stages and in more severe COPD [40].
As mild emphysema may also present without airflow
limitation and collapse, one may hypothesize that the
angle is rather representative of airway obstruction than of
emphysema per se. It is obvious that the severity of
emphysema is closely related to COPD severity, but the
fact that within each former GOLD category patients
with emphysema have significantly lower angles compared
Figure 3 Receiver operating characteristic (ROC) curve analysis. Panel A/ ROC curve of AC to diagnose emphysema. Panels B-E/ Scatter
graph of different variables within emphysema subjects and non-emphysema subjects. The horizontal line represents the best cut-off
for sensitivity-specificity.
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the angle quantifies flow limitation beyond FEV1. From
a physiological point of view, airway obstruction must
present with a curvilinear decrease of flow versus volume,
whereas sudden drops in flow for little volume changesTable 5 Relationship between functional variables and
densitometric quantification of emphysema by multivariate
linear regression model with stepwise selection
Variables Partial R2 value Model R2 value p value
1.
AC, degrees 0.1938 0.1938 <.0001
KCO, %predicted 0.0404 0.2342 <.0001
2.
AC, degrees 0.1939 0.1939 <.0001
FEV1/FVC 0.0074 0.2013 0.0385
FEV1, %predicted 0.0083 0.2097 0.0280
1/ Variables of spirometry (initial model: AC, FVC,%pred, FEV1,%pred, FEV1/
FVC); 2/ Variables of spirometry and diffusion capacity (initial model: AC, FVC,
%pred, FEV1,%pred, FEV1/FVC, DL,CO,%pred, KCO,%pred).are representative of collapse [41]. Although AC is sensi-
tive to collapse and closely relates to emphysema, we do
not claim that AC is a unique characteristic of emphy-
sema, as this also not the case for decreased diffusion
capacity either. Moreover, future studies with dynamic
CT scans are required to differentiate with dynamic
collapse of the central airways in case of tracheo-
bronchomalacia, often occurring in severe COPD [42].
Despite the fact that we confirmed our findings in a
second independent cohort, our study has some limitations.
Most importantly, we used validated semi-quantitative
or visual scores for the characterization of emphysema
because CT scans were obtained in clinical routine with
different CT equipment, different acquisitions and variable
use of intravenous contrast. When using automated density
measures of emphysema (defined as the percentage of
voxels below −950 Hounsfield Units (HU) at inspiration),
we found the expected poor relationships between AC
and emphysema percentage (R2 = 0.1948, p < 0.0001) [43].
Although we know that these relationships are not perfect
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the COPD Gene study), correlations between automated
scores and PFT measures usually reaches twice the value
of ours [44,45]. Surprisingly, multivariate regression still
retained AC as best indicator for emphysema determined
on HU, which indicate that the observed relationships
with AC are independent of the methodology to measure
emphysema. Another limiting factor of this study is the
incapability of the algorithm to correctly compute the
best fitting regression lines in all cases. Nevertheless,
when taking into account badly performed maneuvers,
flow fluctuation and curvilinear flow volume loops,
correct computation between 180° and 90° was possible
in approximately 95% of individuals. Finally, our method
failed in terms of sensitivity and is therefore less useful
as screening tool for the early detection of emphysema.
This occurrence is inevitable due the fact that airflow
limitation may be absent in patients with early emphysema,
often only appearing on CT scan [46]. Whether it is
clinically relevant to be diagnosed at this early stage
when airflow limitation and collapse are not yet present,
remains to be explored.
Taken together, our data provide strong evidence that
airway collapse is one of the best lung functional
correlates of visually assessed emphysema on CT scan.
In primary care, detection of emphysema on spirometry
may identify a population at risk for clinical deterior-
ation and specific follow-up.
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